Matches in SemOpenAlex for { <https://semopenalex.org/work/W4232199021> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4232199021 endingPage "721" @default.
- W4232199021 startingPage "715" @default.
- W4232199021 abstract "We sought to determine whether a low-dose combination of a bile acid–binding resin (colestipol) with an hydroxymethylglutaryl CoA reductase inhibitor (pravastatin) would result in improved acceptability, compliance, and effectiveness in lipid-lowering compared with conventional therapy with a higher dose of a bile acid–binding resin only, with fewer side effects. We performed a randomized, crossover open-label clinical trial with two 18-wk medication regimens separated by an 8-wk washout period in 36 children and adolescents with familial hypercholesterolemia or familial combined hyperlipidemia. The regimens included colestipol 10 g/d (10 pills) versus a combination of colestipol 5 g/d with pravastatin 10 mg/d (six pills). All patients were maintained on a fat-reduced diet. Acceptability was better with the combination regimen. Mean compliance was similar and suboptimal (approximately 60%) with all medication components. Mean relative LDL cholesterol lowering was significantly better with the combination regimen (−17 ± 16%versus −10 ± 13%;p = 0.045), although insufficient to achieve recommended target values in the majority of patients on either regimen. Both regimens were equally free of adverse effects, with no important effect on chemistry or hematologic values. Patient-reported adverse effects were more common with the conventional-dose colestipol-only regimen. Compliance with medication regimens using the bile acid–binding resins is suboptimal, although combination with a low dose of a statin may result in better lipid lowering." @default.
- W4232199021 created "2022-05-12" @default.
- W4232199021 creator A5007394394 @default.
- W4232199021 date "2002-06-01" @default.
- W4232199021 modified "2023-09-26" @default.
- W4232199021 title "A Randomized Crossover Trial of Combination Pharmacologic Therapy in Children with Familial Hyperlipidemia" @default.
- W4232199021 doi "https://doi.org/10.1203/01.pdr.0000015127.99522.7f" @default.
- W4232199021 hasPublicationYear "2002" @default.
- W4232199021 type Work @default.
- W4232199021 citedByCount "0" @default.
- W4232199021 crossrefType "journal-article" @default.
- W4232199021 hasAuthorship W4232199021A5007394394 @default.
- W4232199021 hasBestOaLocation W42321990211 @default.
- W4232199021 hasConcept C126322002 @default.
- W4232199021 hasConcept C134018914 @default.
- W4232199021 hasConcept C142724271 @default.
- W4232199021 hasConcept C168563851 @default.
- W4232199021 hasConcept C197934379 @default.
- W4232199021 hasConcept C204787440 @default.
- W4232199021 hasConcept C27081682 @default.
- W4232199021 hasConcept C2776999253 @default.
- W4232199021 hasConcept C2778163477 @default.
- W4232199021 hasConcept C2779091943 @default.
- W4232199021 hasConcept C2779120738 @default.
- W4232199021 hasConcept C2779399885 @default.
- W4232199021 hasConcept C2779519902 @default.
- W4232199021 hasConcept C2781413609 @default.
- W4232199021 hasConcept C555293320 @default.
- W4232199021 hasConcept C71924100 @default.
- W4232199021 hasConcept C81603835 @default.
- W4232199021 hasConcept C87813604 @default.
- W4232199021 hasConcept C90924648 @default.
- W4232199021 hasConcept C98274493 @default.
- W4232199021 hasConceptScore W4232199021C126322002 @default.
- W4232199021 hasConceptScore W4232199021C134018914 @default.
- W4232199021 hasConceptScore W4232199021C142724271 @default.
- W4232199021 hasConceptScore W4232199021C168563851 @default.
- W4232199021 hasConceptScore W4232199021C197934379 @default.
- W4232199021 hasConceptScore W4232199021C204787440 @default.
- W4232199021 hasConceptScore W4232199021C27081682 @default.
- W4232199021 hasConceptScore W4232199021C2776999253 @default.
- W4232199021 hasConceptScore W4232199021C2778163477 @default.
- W4232199021 hasConceptScore W4232199021C2779091943 @default.
- W4232199021 hasConceptScore W4232199021C2779120738 @default.
- W4232199021 hasConceptScore W4232199021C2779399885 @default.
- W4232199021 hasConceptScore W4232199021C2779519902 @default.
- W4232199021 hasConceptScore W4232199021C2781413609 @default.
- W4232199021 hasConceptScore W4232199021C555293320 @default.
- W4232199021 hasConceptScore W4232199021C71924100 @default.
- W4232199021 hasConceptScore W4232199021C81603835 @default.
- W4232199021 hasConceptScore W4232199021C87813604 @default.
- W4232199021 hasConceptScore W4232199021C90924648 @default.
- W4232199021 hasConceptScore W4232199021C98274493 @default.
- W4232199021 hasIssue "6" @default.
- W4232199021 hasLocation W42321990211 @default.
- W4232199021 hasOpenAccess W4232199021 @default.
- W4232199021 hasPrimaryLocation W42321990211 @default.
- W4232199021 hasRelatedWork W2055974197 @default.
- W4232199021 hasRelatedWork W2074541010 @default.
- W4232199021 hasRelatedWork W2095375351 @default.
- W4232199021 hasRelatedWork W2136983298 @default.
- W4232199021 hasRelatedWork W2171066682 @default.
- W4232199021 hasRelatedWork W2370296599 @default.
- W4232199021 hasRelatedWork W2386048745 @default.
- W4232199021 hasRelatedWork W2807642401 @default.
- W4232199021 hasRelatedWork W3014308787 @default.
- W4232199021 hasRelatedWork W4232199021 @default.
- W4232199021 hasVolume "51" @default.
- W4232199021 isParatext "false" @default.
- W4232199021 isRetracted "false" @default.
- W4232199021 workType "article" @default.